Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients
Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients
The aim of this study is to establish a clinical score panel based on clinical, molecular and
 genetic parameters that allow us to stratify and obtain an early detection of patients with
 an increased risk of developing hepatocellular carcinoma (HCC).
Transversal study design like a "proof of concept".

 Primary objective:

 The main objective is try to stablish a descriptive panel (first phase of a score system)
 based in the conjunction or sum of several clinical and laboratory parameters (molecular and
 genetic factors). The aim is to detect in a fast, early and successful way those patients
 that presents a high risk to develop an hepatocellular carcinoma (HCC) in the future in a
 specific population: HIV and HCV coinfected patients. The establishment of this panel will
 allow clinicians set up a correct treatment decreasing the probability of liver cirrhosis and
 HCC.
Inclusion Criteria:

 -  Human immunodeficiency virus chronic infection

 -  Hepatitis C virus chronic infection

 -  No other liver viral coinfections

 Exclusion Criteria:

 -  Alcohol consume

 -  Immunosuppressor or immunoactive treatment